Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
InhaleRx Limited ( (AU:IRX) ) has provided an announcement.
InhaleRx Limited has announced the application for quotation of 4,499,914 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of previously announced transactions and is expected to enhance the company’s capital structure, potentially improving its market positioning and offering new opportunities for stakeholders.
More about InhaleRx Limited
InhaleRx Limited operates in the pharmaceutical industry, focusing on the development and commercialization of inhalation-based drug delivery systems. The company is dedicated to providing innovative solutions for respiratory health, targeting both consumer and medical markets.
Average Trading Volume: 168,529
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$7.04M
For a thorough assessment of IRX stock, go to TipRanks’ Stock Analysis page.